Index

Title of Article

Row

Paybast S, Abutorabi-Zarchi M, Ashtari F, Baghbanian SM, Moghadam NB, Ebadi Z, Eidi A, Ghaffari M, Langroodi HG, Heidari H, Hosseini S, Kamali H. Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS–infectious disease group. Multiple Sclerosis and Related Disorders. 2026:106824. IF:2.9

Abolfazli R, Sahraian MA, Shaygannejad V, Ashtari F, Shahmohammadi S, Poursadeghfard M, Baghbanian SM, Majdinasab N, Nahayati MA, Hosseini S, Azarfam JY. Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivity. Journal of Clinical Neuroscience. 2026 Apr 1;146:111877. IF:1.8

Kamali M, Ansari M, Nooraee P, Tajadini H, Kamali H, Dehesh T, Ashrafzadeh A, Sharififar F. Preliminary clinical evaluation of capsules containing standard hydroalcoholic extract of Myrtus communis L. in patients with mild to moderate Alzheimer’disease: a randomized, double-blind parallel-group clinical trial. BMC Complementary Medicine and Therapies. 2026 Jan 5. IF:3.4 

Moghadas F, Jafari E, Togha M, Rezaeian B. Clinical profile and final diagnoses of hospitalized patients with a chief complaint of headache, an experience from a headache tertiary center in Iran. BMC neurology. 2026 Feb 3;26(1):144. doi: 10.1186/s12883-026-04686-y. IF:2.2 

Mariki A, Mousavi SM, Kohlmeier KA, Kamali H, Shabani M. Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis. Personalized Medicine. 2026 May 4;23(3):261-74. IF:1.8

Samareh A, Nematollahi MH, Pourghadamyari H, Rastegar S, Ebrahimi H, Hadizadeh M, Wang H, Tao L, Sasan H, Asadikaram G. CRISPR/Cas9-mediated knockout of NEAT1 attenuates neurotoxicity in 6-hydroxydopamine model of Parkinson’s disease. Iranian Journal of Basic Medical Sciences. 2026 Jun 1;29(6):915. IF:2.7 

Fazayeli  Rad  B, Jamaladini  FA,  Etminan  A,  Gozashti  M. Diabetic  Nephropathy  and  the  Risk  of  Cardiac  Arrhythmia: Association between Macroalbuminuria and QTc Interval. Iranian journal of diabetes and metabolism. 2026;26(2):170-181. DOI: https://doi.org/10.18502/ijdl.v26i2.21920

Farham F, Onan D, Moghadas F, Martelletti P. Different Methods of Treatment with Onabotulinum Toxin A in Chronic Migraine and Different Types of Botulinum Toxin Used. SN Comprehensive Clinical Medicine. 2026 Jul 13;8(1):298.

Parizi MA, Nejhad SE, Meimand HA. Guillain–Barré syndrome and its variants during COVID-19 pandemic: a retrospective study in Iran. BMC neurology. 2026 Jul 20. IF:2.2 

Rameshk M, Khaksari Hadad M, Ebrahimi Meimand HA, Raji-Amirhasani A. The Effect of Inflammation on Pentylenetetrazol Induced Seizures in Rats. Journal of Kerman University of Medical Sciences. 2026 Jun 6;33(1):1-8.

Farahmandfard MA, Khanjani N, Ebrahimi Meimand HA, Kamali H, Mirzai M. The Relation Between Air Pollution and Multiple Sclerosis Hospitalization in Kerman. Journal of Health Scope. 2026 Aug 1;15(3):1. IF:1.4

Bakhshinejad B, Sabahi A, Dehesh T, Sarhadynejad Z, Mehrabani M, Khazaneha M, Mehrbani M, Mehrabani M. Efficacy of the herbal product of Cuscuta campestris Yunck. and Polypodium vulgare L. in patients with obsessive-compulsive disorder: A triple-blind clinical trial. Journal of Ethnopharmacology. 2025 Aug 21:120452. IF:6.8

Pardakhty S, Najafipour H, Jafari E, Akbari MM, Keyhani A, Shahraki S, Fekri MS, Bejeshk MA, Rajizadeh MA. Myrtenol inhalation ameliorates lung injury induced by cigarette smoke in rats: the role of inflammation and oxidative stress. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026 Sep 18:1-2. IF:4

Baghbani F, Tajadiny L, Afshari SA, Houni MS, Baniasadi AK, Ghazanfarpour M, Mirzaee F, Dehghanipour M, Ahmadi A. Comparison of depression, anxiety, stress, and health-related quality of life in patients with recurrent and acute vulvovaginal candidiasis.